Unapproved Use of Ivermectin Press Release

Press Releases

Veterinary Ivermectin is used for control of parasites in animals and has not been approved for use in humans for Covid 19 as there has not been any research presented to the National Regulatory Authorities to demonstrate the effectiveness of the product for the condition. The use of any medical product for indications that have […]

BoMRA Press Release Listing of Medical Devices

Press Releases

Botswana Medicines Regulatory Authority (BoMRA) is calling on ALL STAKEHOLDERS OF MEDICAL DEVICES in Botswana to list their medical devices and In-Vitro Diagnostics (IVDs) devices with the Authority.

Press Release – unlicensed products

Press Releases

This serves to inform the general public that the sale, promotion and distribution of any medical products, medical devices & cosmetics in Botswana are governed by the Medicines and Related Substances Act of 2013 (MRSA). This Act led to the establishment of Botswana Medicines Authority (BOMRA), a statutory body under the Ministry of Health and […]

BoMRA Press Release DPER Stakeholder engagements (October)

Press Releases

The Department of Product Evaluation & Registration at BoMRA will conduct stakeholder sessions to discuss the registration requirements for medical devices, veterinary medicines, human medicines and exemption from registration of human medicines.

Expression of interest (Calibration of Infrared Thermometers)

Press Releases

The Botswana Medicines Regulatory Authority (BoMRA) is responsible for regulating the supply chain of human and veterinary medicines, medical devices and cosmetics to ensure their safety, quality and efficacy. BoMRA intends to provide recognition to calibration service providers for medical infrared thermometers. Temperature screening of members of the public using infrared thermometers has become a […]

Suspension Of Registration of GrandPa Products

Press Releases

The public, healthcare practitioners, importers and distributors are informed that registrations of Grand-Pa Headache products (Powder and tablets) have been suspended from the Botswana market with immediate effect. This follows a decision by the Market Authorization Holder GlaxoSmithKline CH South Africa to temporarily halt the supply of these products to Botswana and other markets. This […]

Important Public Warning

Press Releases

Botswana Medicines Regulatory Authority (BoMRA) reminds consumers to be cautious of stores and websites selling products that claim to prevent, mitigate, treat, diagnose or cure serious illnesses, including Covid-19. Some of the fake products claim to kill disease agents such coronavirus, the agent that causes the Covid-19 disease.

Ask your pharmacist about Covid-19

Press Releases

Pharmacists, like other frontline healthcare professionals, are risking their lives for the well-being of their patients during COVID-19 pandemic. Here is what you can do to protect them.

Botswana Medicines Regulatory Authority
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.